Stool Transplants May Boost Immunotherapy Success in Melanoma

In patients with advanced and metastatic melanoma, fecal microbiota transplant from healthy donors given before anti–PD-1 immunotherapy led to a 75% clinical benefit rate.
MDedge News

source https://www.medscape.com/viewarticle/984710?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?